Digene Fights Antitrust Charges As Part Of HPV Diagnostics Patent Case
This article was originally published in The Gray Sheet
Executive Summary
Human papillomavirus test maker Digene, recently acquired by Qiagen, is defending itself against allegations of anti-competitive business practices from Third Wave Technologies as part of a larger patent battle between the firms